Clinical Trial Update: Simvastatin in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating simvastatin for chronic obstructive pulmonary disease (including emphysema) is reported, but the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of East Anglia | Conditions: COPD, Emphysema | Phase 4 | Status: UNKNOWN